Physician profile
Yi Deng
NPI 1508181058
$689.69
in general payments reported to CMS, 2019-2025
7 companies · $67.08 in 2025
The $67.08 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $41.51 · 2023: $55.37 · 2024: $326 · 2025: $67.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239 · Consulting Fee: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.18 |
| Consulting Fee | $209.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $209.00 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $200.00 | 2021 | |
| Erbe USA INC | $116.73 | 2024 | |
| Edwards Lifesciences Corporation | $55.37 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Hemosphere |
| Abiomed | $45.39 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $41.51 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.69 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Deng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.